Targeting Aurora Kinase B Attenuates Chemoresistance in Glioblastoma via a Synergistic Manner with Temozolomide

ConclusionElevated AURKB expression was strongly correlated to TMZ resistant acquisition and poor prognosis, furthermore, targeting AURKB would be a potential therapeutic target for GBM patients.
Source: Pathology Research and Practice - Category: Pathology Source Type: research